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ABSTRACT
Background: Mesenchymal stromal cells (MSCs) are employed in various different clinical settings in order to 
modulate immune response. Human autologous and allogeneic supplements including platelet derivatives such 
as platelet lysate (PL), platelet-released factors (PRF) and serum are assessed in clinical studies to replace 
fetal bovine serum (FBS). The immunosuppressive activity and multi-potential characteristic of MSCs appear 
to be maintained when the cells are expanded in platelet derivatives.
Materials and Methods: Platelet-rich plasma was collected from umbrical cord blood (UCB). Platelet-derived 
growth factors obtained by freeze and thaw methods. 62CD P expression was determined by flow cytometry. 
The concentration of PDGF-BB and PDGF-AB was detemined by ELISA. We tested the ability of a different 
concentration of PL-supplemented medium to support the ex vivo expansion of Wharton's jelly derived MSCs. 
We also investigated the biological/functional properties of expanded MSCs in presence of different 
concentration of PL. The conventional karyotyping was performed in order to study the chromosomal stability. 
The gene expression of Collagen I and II aggrecan and SOX-9 in the presence of different concentrations of PL 
was evaluated by Real-time PCR.
Results: 5% 10%We observed  and  PL, causing greater effects on proliferation of MSCs .These cells exhibited 
typical morphology, immunophenotype and differentiation capacity. The genetic stability of these derivative 
cells from Wharton's jelly was demonstrated by a normal karyotype. Furthermore, the results of Real-time 
PCR analysis showed that the expression of chondrocyte specific genes was higher in MSCs in the presence of 
5% 10% and  PL, compared with FBS supplement.
Conclusions: We demonstrated that PL could be used as an alternative safe source of growth factors for 
expansion of MSCs and also maintained similar growing potential and phenotype without any effect on 
chromosomal stability.
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INTRODUCTION
   Mesenchymal stem cells (MSCs) are multipotent 
cells that can differentiate into several types of 
cells. The first published report by Friedenstein et 
al. describing the expansion of an adherent, spindle-
shaped population of cells from whole human bone 
marrow.1,2 MSCs or MSC-like cells have also been 
expanded from other tissues including adipose 
tissue, umbilical cord blood (UCB), dental pulp, 
amniotic fluid, and numerous other sources.2,3
Human MSCs (hMSCs) also have 
